These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 33982799)

  • 1. NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells.
    Chiou JT; Huang NC; Huang CH; Wang LJ; Lee YC; Shi YJ; Chang LS
    J Cell Physiol; 2021 Nov; 236(11):7356-7375. PubMed ID: 33982799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells.
    Chiou JT; Huang CH; Wu TH; Wang LJ; Lee YC; Huang PW; Chang LS
    Toxicol Appl Pharmacol; 2022 Jan; 435():115847. PubMed ID: 34963561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells.
    Chiou JT; Lee YC; Wang LJ; Chang LS
    Chem Biol Interact; 2022 Jul; 361():109978. PubMed ID: 35561756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells.
    Chiou JT; Chang LS
    Biochem Pharmacol; 2024 Jun; 224():116242. PubMed ID: 38679209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells.
    Chiou JT; Wu YY; Lee YC; Chang LS
    Biochem Pharmacol; 2023 Sep; 215():115738. PubMed ID: 37562509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSK3β suppression inhibits MCL1 protein synthesis in human acute myeloid leukemia cells.
    Lee YC; Shi YJ; Wang LJ; Chiou JT; Huang CH; Chang LS
    J Cell Physiol; 2021 Jan; 236(1):570-586. PubMed ID: 32572959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression.
    Chiou JT; Chang LS
    Apoptosis; 2024 Apr; 29(3-4):503-520. PubMed ID: 38066391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytarabine-induced destabilization of MCL1 mRNA and protein triggers apoptosis in leukemia cells.
    Chiou JT; Hsu CC; Hong YC; Lee YC; Chang LS
    Biochem Pharmacol; 2023 May; 211():115494. PubMed ID: 36924905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway.
    Tauchi T; Moriya S; Okabe S; Kazama H; Miyazawa K; Takano N
    PLoS One; 2024; 19(7):e0307662. PubMed ID: 39052583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression.
    Changchien JJ; Chen YJ; Huang CH; Cheng TL; Lin SR; Chang LS
    Toxicol Appl Pharmacol; 2015 Apr; 284(1):33-41. PubMed ID: 25684043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1.
    Lee YC; Chen YJ; Huang CH; Chang LS
    Apoptosis; 2017 Mar; 22(3):406-420. PubMed ID: 27757735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells.
    Chen YJ; Huang CH; Shi YJ; Lee YC; Wang LJ; Chang LS
    Toxicol Appl Pharmacol; 2018 Nov; 358():43-55. PubMed ID: 30213730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
    Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
    J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477.
    Mallick DJ; Soderquist RS; Bates D; Eastman A
    Cell Death Dis; 2019 Feb; 10(3):185. PubMed ID: 30796196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
    Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted inhibition of ULK1 enhances daunorubicin sensitivity in acute myeloid leukemia.
    Qiu L; Zhou G; Cao S
    Life Sci; 2020 Feb; 243():117234. PubMed ID: 31887299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells.
    Chiou JT; Lee YC; Huang CH; Shi YJ; Wang LJ; Chang LS
    Toxicol Appl Pharmacol; 2020 Jan; 387():114857. PubMed ID: 31837377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxyl group-modified α-lactalbumin induces TNF-α-mediated apoptosis in leukemia and breast cancer cells through the NOX4/p38 MAPK/PP2A axis.
    Chiou JT; Shi YJ; Lee YC; Wang LJ; Chen YJ; Chang LS
    Int J Biol Macromol; 2021 Sep; 187():513-527. PubMed ID: 34310992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia.
    Ramsey HE; Fischer MA; Lee T; Gorska AE; Arrate MP; Fuller L; Boyd KL; Strickland SA; Sensintaffar J; Hogdal LJ; Ayers GD; Olejniczak ET; Fesik SW; Savona MR
    Cancer Discov; 2018 Dec; 8(12):1566-1581. PubMed ID: 30185627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells.
    Zhao J; Niu X; Li X; Edwards H; Wang G; Wang Y; Taub JW; Lin H; Ge Y
    Oncotarget; 2016 Jun; 7(23):34785-99. PubMed ID: 27166183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.